Recombinant Factor VIIa Is Associated With an Improved 24-Hour Survival Without an Improvement in Inpatient Survival in Massively Transfused Civilian Trauma Patients . Clinics 2011, 66 (1), 101-106. https://doi.org/10.1590/S1807-59322011000100018.